98%
921
2 minutes
20
Background: Multidisciplinary conferences (MDC) for rectal cancer yield benefits to patients; however, whether they confer benefits to clinicians has not been explicitly investigated. This qualitative study evaluates the impact of our local rectal cancer MDC on physician participants.
Materials And Methods: Semi-structured interviews were conducted via a virtual video-calling platform and recorded and transcribed. Participants included staff clinicians and fellowship-level trainees from medical oncology, radiation oncology, surgery, radiology, and pathology, all of whom participate in our weekly rectal cancer MDC. Qualitative analysis using NVivo was completed, and themes and subthemes were coded and tabulated using a constant comparative method.
Results: A total of 21 clinicians participated in the study, representing all five disciplines. Four major themes were identified: benefits, challenges, successes, and improvements. The most significant major theme was benefits, discussed by all 21 participants. Subthemes in this category were benefits to clinicians, which included academic opportunities and strengthening of interdisciplinary communication and collegiality. Major themes also included challenges and successes, mentioned in all interviews, as well as improvements, which were mentioned in most interviews. Subthemes in the challenges category included timing of meetings and workload. Subthemes for successes included the virtual platform as well as adequate representation and administrative support.
Conclusions: Multidisciplinary conference has added value beyond that which is experienced by patients. This includes enhanced interdisciplinary communication and collegiality, which in turn can impact overall physician satisfaction. Challenges are inherent, including workload and accessibility; however, these can be balanced with administrative support and virtual platform.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1245/s10434-025-17979-2 | DOI Listing |
Int Urol Nephrol
September 2025
Department of Urology, Brigham and Women's Hospital, Harvard Medical School, 45 Francis St, ASB II-3, Boston, MA, 02115, USA.
Background: With the advancement of MR-based imaging, prostate cancer ablative therapies have seen increased interest to reduce complications of prostate cancer treatment. Although less invasive, they do carry procedural risks, including rectal injury. To date, the medicolegal aspects of ablative therapy remain underexplored.
View Article and Find Full Text PDFAnn Surg Oncol
September 2025
Department of Surgery, Divisions of Surgical Oncology, Colon and Rectal Surgery, Immunotherapy, University of Louisville School of Medicine, Louisville, KY, USA.
Cardiovasc Intervent Radiol
September 2025
Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Background: To evaluate predictors of outcomes in colorectal liver metastases (CLM) patients undergoing 90Y radioembolization (TARE), focusing on the impact of tumor absorbed dose.
Materials And Methods: Patients' characteristics and dosimetry assessments were analyzed in 231 patients undergoing 329 TARE sessions from 09/2009 to 07/2023. Response was assessed using RECIST1.
BJS Open
September 2025
Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Background: Metastases in the lateral pelvic lymph nodes or mesenteric lymph nodes represent distinct categories of mid-low rectal cancer. This study investigated the patterns of mesenteric and lateral pelvic lymph node metastases in mid-low rectal cancer; the survival benefit of postoperative treatment was also analysed in these groups.
Methods: This retrospective multicentre study included consecutive patients with mid-low rectal cancer who underwent total mesorectal excision with lateral pelvic lymph node dissection in three Chinese institutions between 2012 and 2020.
Khirurgiia (Mosk)
September 2025
National Medical Research Center of Oncology, Rostov-on-Don, Russia.
Objective: To study the results of treatment of cancer in tubular villous adenomas.
Material And Methods: A retrospective analysis included 51 patients with cTis-T1N0M0 between 02.2019 and 09.